Drug profile · INN
beractant
SURVANTA
beractant (SURVANTA) is a surfactant agent. Route of administration: intratracheal. Current US regulatory status: approved.
FDA: approved
US status approved
Patents linked 0
Pipeline programs 3
News articles 0
Drug details — beractant
- US status
- approved
- Class
- —
- Route
- INTRATRACHEAL
- Patents
- 0
- Programs
- 3
- Data quality
- 0.84
Quick answer
beractant (SURVANTA) is a surfactant agent. Route of administration: intratracheal. Current US regulatory status: approved.
Key facts
INN beractant
Brand SURVANTA
Mechanism Surfactant agent
Route INTRATRACHEAL
Formulation SUSPENSION
Mechanism of action
Surfactant agent
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Frequently asked questions
What is beractant?
beractant (SURVANTA) is a surfactant agent. Route of administration: intratracheal. Current US regulatory status: approved.
What is the brand name for beractant?
SURVANTA is a marketed brand name for beractant. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of beractant?
beractant has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.